Additional file 2 of Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity

Additional file 2: Supplementary Fig. 1 The status of metastatic disease of breast cancer patients with ErbB2-positive metastatic breast cancer whose blood was used in the study. (a) The disease status was determined in the case of each patient based on the comparison of CT scan 2 with CT scan 1 using Response Evaluation Criteria in Solid Tumors. Treatment regimens received by each patient during the time period when the blood was collected are indicated. The dates of the CT scans are indicated. (b) CT scans of patient 1 performed on the indicated dates are shown as examples of imaging studies used by us. Comparison of the scans shows that patient’s axillary lymph node was smaller on 07/23/18 than on 05/14/18.